Table 2.
Daily Fluoride Intake Period | ||||||||
|
||||||||
Radius | ||||||||
|
||||||||
Females | Males | |||||||
|
||||||||
Bone Measures | 0–8.5 years (n=176) | 8.5–14 years (n=160) | 14–17 years (n=154) | 0–17 years (n=139) | 0–8.5 years (n=160) | 8.5–14 years (n=137) | 14–17 years (n=138) | 0–17 years (n=125) |
|
||||||||
Trabecular | ||||||||
| ||||||||
Trabecular content (mg) | 0.03 | 0.09 | 0.13 | 0.08 | 0.04 | 0.04 | 0.17* | 0.05 |
| ||||||||
Trabecular density (mg/cm3) | 0.05 | 0.09 | 0.13 | 0.07 | 0.03 | 0.05 | 0.15 | 0.04 |
| ||||||||
Cortical | ||||||||
| ||||||||
Cortical content (mg) | 0.004 | 0.15 | 0.10 | 0.10 | 0.07 | 0.07 | 0.19* | 0.12 |
| ||||||||
Cortical density (mg/cm3) | 0.02 | − 0.03 | −0.02 | −0.02 | 0.09 | 0.06 | 0.07 | 0.13 |
| ||||||||
Strength | ||||||||
| ||||||||
BSI (mg2/mm4) | 0.01 | 0.14 | 0.13 | 0.08 | 0.09 | 0.09 | 0.24** | 0.16 |
| ||||||||
pSSI (mm3) | 0.01 | 0.11 | 0.10 | 0.10 | 0.09 | 0.08 | 0.18* | 0.13 |
| ||||||||
Tibia | ||||||||
|
||||||||
Females | Males | |||||||
|
||||||||
| ||||||||
Bone Measures | 0–8.5 years (n=176) | 8.5–14 years (n=160) | 14–17 years (n=154) | 0–17 years (n=139) | 0–8.5 years (n=160) | 8.5–14 years (n=137) | 14–17 years (n=138) | 0–17 years (n=125) |
| ||||||||
Trabecular | ||||||||
| ||||||||
Trabecular content (mg) | 0.14 | 0.14 | 0.12 | 0.14 | 0.06 | 0.05 | 0.27** | 0.11 |
| ||||||||
Trabecular density (mg/cm3) | 0.05 | 0.01 | 0.09 | −0.02 | 0.09 | 0.11 | 0.22* | 0.16 |
| ||||||||
Cortical | ||||||||
| ||||||||
Cortical content (mg) | 0.05 | 0.16 | 0.20* | 0.11 | 0.13 | 0.19* | 0.30** | 0.24* |
| ||||||||
Cortical density (mg/cm3) | 0.07 | −0.08 | −0.16 | −0.05 | 0.11 | −0.03 | 0.01 | 0.07 |
| ||||||||
Strength | ||||||||
| ||||||||
BSI (mg2/mm4) | 0.03 | 0.15 | 0.19* | 0.10 | 0.13 | 0.14 | 0.27** | 0.22* |
| ||||||||
pSSI (mm3) | 0.05 | 0.21* | 0.21** | 0.15 | 0.17* | 0.18* | 0.30** | 0.25** |
Significant at 0.05 level
Significant at 0.01 level